EUR 3.8
(0.53%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.14 Million EUR | -100.34% |
2022 | 3.85 Million EUR | 142.73% |
2021 | 1.58 Million EUR | 42.62% |
2020 | 1.11 Million EUR | -13.19% |
2019 | 1.28 Million EUR | -46.91% |
2018 | 2.41 Million EUR | 27.12% |
2017 | 1.9 Million EUR | 20.27% |
2016 | 1.58 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 FY | -12.95 Thousand EUR | -100.34% |
2023 Q4 | 1.27 Million EUR | 0.0% |
2023 Q2 | 8208.00 EUR | 0.0% |
2022 Q2 | 849.01 Thousand EUR | 0.0% |
2022 FY | 3.85 Million EUR | 142.73% |
2022 Q4 | 950.84 Thousand EUR | 0.0% |
2021 Q2 | 804.12 Thousand EUR | 0.0% |
2021 FY | 1.58 Million EUR | 42.62% |
2021 Q4 | 785.73 Thousand EUR | 0.0% |
2020 Q2 | 468.59 Thousand EUR | 0.0% |
2020 Q4 | 646.16 Thousand EUR | 0.0% |
2020 FY | 1.11 Million EUR | -13.19% |
2019 Q4 | 587.81 Thousand EUR | 0.0% |
2019 FY | 1.28 Million EUR | -46.91% |
2019 Q2 | 696.37 Thousand EUR | 0.0% |
2018 Q2 | 756.15 Thousand EUR | 401.47% |
2018 Q1 | 150.78 Thousand EUR | -80.69% |
2018 FY | 2.41 Million EUR | 27.12% |
2018 Q4 | 1.8 Million EUR | 0.0% |
2017 Q2 | 1.04 Million EUR | 1593.82% |
2017 Q4 | 780.97 Thousand EUR | 0.0% |
2017 Q1 | 61.61 Thousand EUR | 0.0% |
2017 FY | 1.9 Million EUR | 20.27% |
2016 FY | 1.58 Million EUR | 0.0% |
2016 Q4 | 61.61 Thousand EUR | 0.0% |
2016 Q2 | 64.47 Thousand EUR | 0.0% |
2016 Q1 | 64.47 Thousand EUR | 0.0% |
2015 Q4 | 64.47 Thousand EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Biosynex SA | 86.53 Million EUR | 95.205% |
bioMĂ©rieux S.A. | 1.44 Billion EUR | 99.713% |
Eurofins Scientific SE | 73.6 Million EUR | 94.362% |
Lumibird SA | 115.93 Million EUR | 96.421% |